Skip to main content

Table 3 Histopathological data

From: Risk assessment of transgender people: implementation of a demasculinizing–feminizing rodent model including the evaluation of thyroid homeostasis

Organ/Observation

 

C

L

M

H

Testis

N

4

4

4

4

Tubule degeneration with germinal epithelium degeneration

 

0/4 ##

1/4 (25%)

2/4 (50%)

4/4 (100%) §

Tubule lumen area (μm2; mean ± SD)

 

133.00 ± 24.06

131.43 ± 30.4

172.35 ± 19.03

84.03 ± 9.39*

Liver

N

4

4

4

4

Sinusoidal dilatation

 

0/4 ##

2/4 (50%)

4/4 (100%) §

4/4 (100%) §

Hepatocyte vacuolization

 

0/4

1/4 (25%)

4/4 (100%) §

2/4 (50%)

Thyroid

N

4

3

4

3

Follicular number (mean ± SD)

 

28.67 ± 10.97

104.00 ± 3.61°

104.67 ± 34.53*

70.33 ± 44.05

Follicular density % (N/μm2; mean ± SD)

 

0.57 ± 0.21

1.93 ± 0.06°

1.90 ± 0.55*

1.73 ± 0.70°

Follicular area (μm2; mean ± SD)

 

49.63 ± 3.48

21.96 ± 9.70°

25.82 ± 5.76°

31.87 ± 9.91°

Colloidal area (μm2; mean ± SD)

 

32.49 ± 1.39

10.5 ± 7.75°

12.40 ± 6.37°

18.62 ± 7.78°

Direct follicular cell height (μm; mean ± SD)

 

8.92 ± 0.81

7.18 ± 1.17

9.20 ± 1.70

8.41 ± 0.89

Area of follicular epithelium (μm2; mean ± SD)

 

1.53 ± 0.14

2.40 ± 0.73

2.03 ± 0.77

1.76 ± 0.19

  1. Histopathological data of testes, liver and thyroid of male rats subcutaneously treated with estradiol valerate plus cyproterone acetate, five times a week for 2 weeks: Control (C): 0—sesame oil, Low (L) 0.045 + 0.2, Medium (M) 0.09 + 0.2 and High (H) 0.18 + 0.2 mg. Statistical significance: § p < 0.05 Fisher exact test; ° p = 0.08, * p < 0.05 Mann–Whitney test; ## p < 0.01 Cochran–Armitage Trend Test. N: samples number; SD: standard deviation.